These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20466238)

  • 21. Optimal management of community-acquired acute bacterial rhinosinusitis: the allergist's perspective.
    Meltzer EO; Weinstein SF; Zitt MJ
    Ann Allergy Asthma Immunol; 2006 Mar; 96(3):390-7. PubMed ID: 16597072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approach of empirical antibiotic treatment: analyzing bacterial resistance of community-acquired bacteremia.
    Young TG; Chen YS; Yen MY
    J Microbiol Immunol Infect; 2010 Feb; 43(1):43-6. PubMed ID: 20434122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of community-acquired pneumonia Down Under versus the United States: is it really that different?
    Mandell L
    Clin Infect Dis; 2008 May; 46(10):1522-4. PubMed ID: 18419485
    [No Abstract]   [Full Text] [Related]  

  • 24. Bronchoalveolar interleukin-1 beta: a marker of bacterial burden in mechanically ventilated patients with community-acquired pneumonia.
    Wu CL; Lee YL; Chang KM; Chang GC; King SL; Chiang CD; Niederman MS
    Crit Care Med; 2003 Mar; 31(3):812-7. PubMed ID: 12626989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is it bacterial or viral? Criteria for distinguishing bacterial and viral infections.
    Benninger M; Segreti J
    J Fam Pract; 2008 Feb; 57(2 Suppl Managing):S5-11. PubMed ID: 18662527
    [No Abstract]   [Full Text] [Related]  

  • 26. Community-acquired pneumonia in adults: initial antibiotic therapy.
    King DE; Pippin HJ
    Am Fam Physician; 1997 Aug; 56(2):544-50. PubMed ID: 9262534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain.
    Tellado JM; Sen SS; Caloto MT; Kumar RN; Nocea G
    Scand J Infect Dis; 2007; 39(11-12):947-55. PubMed ID: 17852889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia.
    Falguera M; Ruiz-González A; Schoenenberger JA; Touzón C; Gázquez I; Galindo C; Porcel JM
    Thorax; 2010 Feb; 65(2):101-6. PubMed ID: 19703825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study on antimicrobial susceptibility of bacteria causing neonatal infections: a 12 year study (1987-1998).
    Yu JL; Wu SX; Jia HQ
    Singapore Med J; 2001 Mar; 42(3):107-10. PubMed ID: 11405560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial.
    Schouten JA; Hulscher ME; Trap-Liefers J; Akkermans RP; Kullberg BJ; Grol RP; van der Meer JW
    Clin Infect Dis; 2007 Apr; 44(7):931-41. PubMed ID: 17342644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinicomicrobiological characteristics of community-acquired infections of the urinary tracts in Moscow].
    Rafal'skiĭ VV; Rokhlikov IM; Strachunskiĭ LS
    Urologiia; 2007; (5):18, 20-3. PubMed ID: 18254219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Appropriate antibiotic utilization in seniors prior to hospitalization for community-acquired pneumonia is associated with decreased in-hospital mortality.
    Johnson D; Carriere KC; Jin Y; Marrie T
    J Clin Pharm Ther; 2004 Jun; 29(3):231-9. PubMed ID: 15153084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy-resistant skin and soft tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus in a young immunocompetent adult.
    Graue N; Korber A; Schmid EN; Rath PM; Dissemond J
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):766-7. PubMed ID: 18482040
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro activity of ertapenem: review of recent studies.
    Wexler HM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [AFSSAPS guidelines for the antibiotic treatment of lower respiratory track infections].
    Agence Française de Sécurité Sanitaire des Produits de Santé
    Rev Mal Respir; 2003 Jun; 20(3 Pt 1):462-9. PubMed ID: 12910125
    [No Abstract]   [Full Text] [Related]  

  • 36. Commensals upon us.
    Alekshun MN; Levy SB
    Biochem Pharmacol; 2006 Mar; 71(7):893-900. PubMed ID: 16464437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy of community-acquired acute bacterial meningitis: the clock is running.
    Klein M; Pfister HW; Leib SL; Koedel U
    Expert Opin Pharmacother; 2009 Nov; 10(16):2609-23. PubMed ID: 19827989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selecting antibiotics for community-acquired skin and skin structure infections in the emergency department.
    Francis KE
    Adv Emerg Nurs J; 2009; 31(1):19-26. PubMed ID: 20118849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Infections and bacterial resistance in the community].
    Goettsch WG; Goossens H; de Neeling AJ; Sprenger MJ
    Ned Tijdschr Geneeskd; 1999 Jun; 143(25):1296-9. PubMed ID: 10416482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae.
    Isozumi R; Yoshimine H; Morozumi M; Ubukata K; Ariyoshi K
    Respirology; 2009 Nov; 14(8):1206-8. PubMed ID: 19732389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.